Validation of a novel integrated approach to describe patients along a spectrum of esophageal dysmotility

Ashton Ellison: NO financial relationship with a commercial interest | Anh Nguyen: NO financial relationship with a commercial interest | Stuart Spechler: YES financial relationship with a commercial interest;Phathom Pharmaceuticals:Consulting;Takeda Pharmaceuticals:Consulting;Ironwood Pharmaceuticals:Consulting;ISOThrive, LLC:Consulting;Cernostics:Consulting;Interpace Diagnostics:Consulting | Eitan Podgaetz: NO financial relationship with a commercial interest | Marc Ward: NO financial relationship with a commercial interest | Daniel Davis: YES financial relationship with a commercial interest;Intuitive Surgical Inc:Speaking and Teaching | Rhonda Souza: YES financial relationship with a commercial interest;Ironwood Pharmaceuticals:Consulting;Cernostics:Consulting;Phathom Pharmaceuticals:Consulting;Phathom Pharmaceuticals:Grant/Research Support;Isothrive:Consulting;CDx Diagnostics:Consulting;AstraZeneca:Consulting;Sanofi:Grant/Research Support | Chanakyaram Reddy: NO financial relationship with a commercial interest | Vani Konda: YES financial relationship with a commercial interest;Medtronic:Speaking and Teaching;Exact:Advisory Committees or Review Panels;Cernostics:Speaking and Teaching;Lucid:Grant/Research Support;Ambu:Consulting